Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
Jane Kirby

THE TRUTH ABOUT: Landmark moment as new pill approved for common type of advanced breast cancer - The Untold Story

A new drug has been approved on the NHS for advanced breast cancer (Alamy/PA) -

A twice-a-day pill for the most common type of advanced breast cancer has been approved on the NHS in what scientists say is a “landmark moment”.

Around 1,100 – and potentially up to 3,000 – women every year could benefit from capivasertib for hormone receptor (HR)-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.